Genic Co. Ltd (123330) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Genic Co. Ltd (123330) has a cash flow conversion efficiency ratio of 0.187x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.70 Billion ≈ $5.22 Million USD) by net assets (₩41.05 Billion ≈ $27.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genic Co. Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Genic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 123330 total debt and obligations for a breakdown of total debt and financial obligations.
Genic Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genic Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lee Ku Ind
KO:025820
|
-0.119x |
|
Amber International Holding Limited
NYSE:AMBR
|
0.226x |
|
Everest Textile Co Ltd
TW:1460
|
-0.004x |
|
Fong Chien Construction Co Ltd
TWO:5523
|
-0.075x |
|
Sunty Development Co Ltd
TW:3266
|
-0.076x |
|
Scicom MSC Bhd
KLSE:0099
|
0.038x |
|
Cavotec SA
ST:CCC
|
0.055x |
|
ESAF Small Finance Bank
NSE:ESAFSFB
|
-0.368x |
Annual Cash Flow Conversion Efficiency for Genic Co. Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Genic Co. Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Genic Co. Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩41.05 Billion ≈ $27.82 Million |
₩20.65 Billion ≈ $13.99 Million |
0.503x | +3990.77% |
| 2024-12-31 | ₩22.15 Billion ≈ $15.01 Million |
₩272.46 Million ≈ $184.64K |
0.012x | +152.86% |
| 2023-12-31 | ₩11.53 Billion ≈ $7.81 Million |
₩-268.31 Million ≈ $-181.83K |
-0.023x | -308.47% |
| 2022-12-31 | ₩15.94 Billion ≈ $10.80 Million |
₩177.94 Million ≈ $120.59K |
0.011x | -93.52% |
| 2021-12-31 | ₩19.30 Billion ≈ $13.08 Million |
₩3.32 Billion ≈ $2.25 Million |
0.172x | +1708.60% |
| 2020-12-31 | ₩22.33 Billion ≈ $15.13 Million |
₩212.66 Million ≈ $144.12K |
0.010x | -81.23% |
| 2019-12-31 | ₩27.14 Billion ≈ $18.39 Million |
₩1.38 Billion ≈ $933.12K |
0.051x | +122.19% |
| 2018-12-31 | ₩38.94 Billion ≈ $26.39 Million |
₩-8.90 Billion ≈ $-6.03 Million |
-0.229x | -203.64% |
| 2017-12-31 | ₩54.27 Billion ≈ $36.78 Million |
₩-4.09 Billion ≈ $-2.77 Million |
-0.075x | -342.20% |
| 2016-12-31 | ₩61.93 Billion ≈ $41.97 Million |
₩1.93 Billion ≈ $1.30 Million |
0.031x | -50.31% |
| 2015-12-31 | ₩58.04 Billion ≈ $39.33 Million |
₩3.63 Billion ≈ $2.46 Million |
0.063x | -40.55% |
| 2014-12-31 | ₩55.16 Billion ≈ $37.38 Million |
₩5.80 Billion ≈ $3.93 Million |
0.105x | +52.34% |
| 2013-12-31 | ₩53.25 Billion ≈ $36.08 Million |
₩3.68 Billion ≈ $2.49 Million |
0.069x | -15.26% |
| 2012-12-31 | ₩52.87 Billion ≈ $35.83 Million |
₩4.31 Billion ≈ $2.92 Million |
0.082x | -- |
About Genic Co. Ltd
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; a… Read more